** Shares of UK-based holding co RUA Life Sciences RUA.L
up 6.1% at 36.6%
** Says HY sales rose 56% and that trading in H1 2023 has
been strong, with revenue ahead of expectations urn:newsml:reuters.com:*:nTUC7Q5ZPF
** RUA's HY loss narrows by 15% to 1.1 mln pounds
** "Our Biomaterials and Contract Manufacturing businesses
have performed very well over the period, which has further
assisted in the tight control of cash, resulting in a strong
cash position at the end of the half year" - Chairman Bill Brown
** Despite the session's gains, stock is still down ~51% YTD
(Reporting by Amna Karimi in Bengaluru)
((Amna.Karimi@thomsonreuters.com; +91 8083261226;))